Variant report
Variant | esv3396822 |
---|---|
Chromosome Location | chr1:75378980-75412094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201408988 | chr1:75389439-75389440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548342412 | chr1:75389450-75389451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576214017 | chr1:75389492-75389493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566578859 | chr1:75389589-75389590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533825175 | chr1:75389590-75389591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545215786 | chr1:75389596-75389597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368287865 | chr1:75389600-75389601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576737861 | chr1:75389657-75389658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537783640 | chr1:75389689-75389690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556421130 | chr1:75389691-75389692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188801882 | chr1:75389796-75389797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574334191 | chr1:75389812-75389813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541632014 | chr1:75389820-75389821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149295818 | chr1:75389821-75389822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572232389 | chr1:75389831-75389832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545861003 | chr1:75389897-75389898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564359579 | chr1:75389902-75389903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78741930 | chr1:75389913-75389914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201004212 | chr1:75389917-75389918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113967949 | chr1:75389924-75389925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562395252 | chr1:75389931-75389932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529568687 | chr1:75389968-75389969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548010393 | chr1:75389973-75389974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76321328 | chr1:75389988-75389989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4949678 | chr1:75389998-75389999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs386632472 | chr1:75390010-75390011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138364289 | chr1:75390011-75390012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78719265 | chr1:75390012-75390013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77774754 | chr1:75390044-75390045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574395556 | chr1:75390060-75390061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535338172 | chr1:75390076-75390077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553568872 | chr1:75390099-75390100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116362262 | chr1:75390100-75390101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546011297 | chr1:75390129-75390130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200853427 | chr1:75390140-75390141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565213307 | chr1:75390143-75390144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376882556 | chr1:75390160-75390161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374245666 | chr1:75390171-75390172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77494417 | chr1:75390173-75390174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576396739 | chr1:75390194-75390195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538584301 | chr1:75403176-75403177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9787288 | chr1:75403177-75403178 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs375712923 | chr1:75403220-75403221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145182516 | chr1:75403254-75403255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553061866 | chr1:75403261-75403262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200778703 | chr1:75403378-75403379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532282220 | chr1:75404032-75404033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535297780 | chr1:75404085-75404086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192919344 | chr1:75404088-75404089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1413991 | chr1:75404117-75404118 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:75389400-75390200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr1:75403000-75403400 | Enhancers | Adipose Nuclei | Adipose |
3 | chr1:75403000-75403400 | Enhancers | Fetal Heart | heart |
4 | chr1:75404000-75404600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:75404000-75404600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr1:75408400-75409400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |